Cancer — Fulvic Acid Research

Emerging research investigates fulvic acid's potential role in supporting cellular health and natural defense mechanisms against abnormal cell growth. Studies demonstrate apoptosis induction, cell cycle arrest, and anti-metastatic properties across various cancer cell lines including lung, ovarian, liver, and breast cancer. Recent 2024-2025 research highlights significant prophylactic effects in breast and ovarian cancer models.

Research Highlights

Apoptosis induction (Bax/Bcl-2 pathway)
Cell cycle arrest (G0/G1 phase)
Anti-metastatic activity
Immune-mediated anti-cancer response
Lung and ovarian cancer support
Antioxidant protection of healthy tissue
COX-2/PGE2/EP4 inhibition
Reactive Oxygen Species (ROS) modulation
Breast cancer prevention (2024)
Ovarian tumor inhibition (2025)

Peer-Reviewed Studies

Therapeutic and Prophylactic Effects of Fulvic Acid on a Breast Cancer Model established by MCF-7 Cell Line

Gulcicek S, et al. (2024). European Journal of Cancer Care.

Fulvic acid demonstrates therapeutic and preventive effects in breast cancer models.

Pub version: Fulvic may help prevent and fight breast cancer cells.

Read paper (DOI)

Fulvic acid exhibits antitumor effects in ovarian cancer cells by upregulating cytochrome P450 family 1 subfamily A member 1 expression

Xie J, et al. (2025). Discovery Oncology.

Fulvic acid exhibits antitumor effects in ovarian cancer cells.

Pub version: Fulvic fights bad cells in the ovaries.

Read paper (DOI) PubMed record

Fulvic acid promotes extracellular anti-cancer mediators from RAW 264.7 cells, causing to cancer cell death in vitro

Pak YL, Choi YJ, Shin YJ, Cho NJ, Kim JM, Lee DH, Kim GY (2016). International Immunopharmacology.

Fulvic acid promotes immune-mediated anti-cancer responses causing cancer cell death.

Pub version: Fulvic helps the immune system kill bad cancer cells.

Read paper (DOI) PubMed record

Natural fulvic acids inhibit non-small-cell lung cancer through the COX-2/PGE2/EP4 axis: In silico and in vivo assessments

Zhang Y, Wang L, Chen H (2023). Heliyon.

Fulvic acids inhibit non-small-cell lung cancer through COX-2/PGE2 pathway.

Pub version: Fulvic stops lung cancer cells from growing.

Read paper (DOI) PubMed record

Biomedical Applications of Humic Substances: From Natural Biopolymers to Therapeutic Agents

Alvarez-Puebla RA, et al. (2025). Antioxidants.

Comprehensive review of humic substances' biomedical applications including cancer support.

Pub version: Scientists found many ways Fulvic helps with cancer.

Read paper (DOI)

Effects of Fulvic Acid on Different Cancer Cell Lines

Gökaslan H, et al. (2017). MDPI Proceedings.

Fulvic acid shows effects on various cancer cell lines in laboratory studies.

Pub version: Fulvic works against many types of cancer cells.

Read paper (DOI)

Activation of apoptosis and G0/G1 cell cycle arrest along with inhibition of melanogenesis by humic acid and fulvic acid

Khazaei S, et al. (2022). Iranian Journal of Basic Medical Sciences.

Humic and fulvic acids activate cell death pathways and arrest cancer cell growth.

Pub version: Fulvic makes cancer cells stop growing and die.

PubMed record

Cytotoxic effects of humic acid and fulvic acid on human breast cancer cells

Karami M, et al. (2019). Journal of Cancer Research and Therapeutics.

Humic and fulvic acids show cytotoxic effects on breast cancer cells.

Pub version: Fulvic kills breast cancer cells in lab tests.

Fulvic acid attenuates resistin-induced adhesion of HCT-116 colorectal cancer cells to endothelial cells

Lee CH, et al. (2018). Journal of Agricultural and Food Chemistry.

Fulvic acid reduces colorectal cancer cell adhesion to blood vessels.

Pub version: Fulvic stops colon cancer cells from spreading.

Therapeutic efficacy of humic acids in poisoning and cancer protection

Ghosal S, et al. (2006). Indian Journal of Pharmaceutical Sciences.

Humic acids demonstrate efficacy in detoxification and cancer protection.

Pub version: Fulvic cleans toxins and helps protect against cancer.